Ablation of ventricular tachycardia in patients with structural heart disease
Katja Zeppenfeld1, William G Stevenson
1Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands. k.zeppenfeld@lumc.nl
Insights
Catheter ablation offers a key treatment for recurrent ventricular arrhythmias in heart disease patients. Advanced mapping techniques now enable precise ablation of scar-related arrhythmias, improving patient outcomes.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Device Technology
Background:
- Recurrent ventricular arrhythmias pose a significant challenge in patients with heart disease.
- Implantable defibrillators are primary therapy, but many patients need additional treatments like antiarrhythmic drugs or ablation.
- Understanding the mechanisms of these arrhythmias is crucial for effective treatment.
Purpose of the Study:
- To review the role and advancements in catheter ablation for ventricular arrhythmias.
- To highlight insights into the pathophysiologic mechanisms driving these arrhythmias.
- To discuss current and future strategies for improving ablation efficacy.
Main Methods:
- Review of studies on mapping and ablation techniques for ventricular arrhythmias.
- Characterization of arrhythmogenic mechanisms, particularly ventricular scar.
- Discussion of electrogram characteristics for identifying ablation targets.
- Exploration of pericardial space access for challenging cases.
Main Results:
- Ventricular arrhythmias are often caused by reentry through scar tissue.
- Electrogram-based scar identification allows targeted ablation even in complex cases.
- Ablation is a viable option for patients with multiple or unstable ventricular tachycardia.
Conclusions:
- Catheter ablation is an important therapy for controlling recurrent ventricular arrhythmias.
- Advances in mapping and ablation technology are improving efficacy.
- Addressing anatomical obstacles, such as through pericardial access, holds promise for further success.
Abstract:
Catheter ablation is an important therapeutic option for controlling recurrent ventricular arrhythmias in patients with heart disease. Although implantable defibrillators are generally first line therapy in this patient population, a substantial number of patients require additional therapy with either antiarrhythmic drugs, ablation, or both. Studies of mapping and ablation have produced further insights into pathophysiologic mechanisms of these arrhythmias, which are now well characterized. The majority is due to reentry through regions of ventricular scar. Methods for identifying scar based on electrogram characteristics now allow arrhythmogenic areas to be targeted for ablation during stable sinus rhythm, such that ablation is often an option even when multiple and unstable ventricular tachycardia are present. Ablation failure can also be due to anatomical obstacles; however, methods for accessing the pericardial space for mapping and ablation and technological progress can be expected to further improve its efficacy.
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias


